Ben Tseng
Nessuna posizione attualmente
Profilo
Ben Tseng was Chief Scientific Officer of EpiCept Corp.
from January 2006 to May 29, 2009.
He was Vice President of Research for Maxim Pharmaceuticals, Inc. Dr. Tseng joined Maxim Pharmaceuticals as Senior Director-Research in 2000.
He was Vice President of Biology for Cytovia, Inc., which he joined in 1998.
Dr. Tseng held various executive research positions at Chugai Biopharmaceutical, Inc. from 1995 to 1998 and Genta, Inc. from 1989 to 1995.
He was an Associate Adjunct Professor in the Department of Medicine, a Faculty Member of the Physiology and Pharmacology Program and an Associate Member of the Cancer Center at the University of California.
Dr. Tseng received a BA degree in Mathematics from Brandeis University and a PhD in Molecular Biophysics and Biochemistry from Yale University.
Precedenti posizioni note di Ben Tseng
| Società | Posizione | Fine |
|---|---|---|
EpiCept Corp.
 EpiCept Corp. Pharmaceuticals: MajorHealth Technology EpiCept Corp. is a pharmaceutical company, which focuses on the clinical development and commercialization of pharmaceutical products for the treatment of cancer and pain. The company focuses on analgesics targeting peripheral nerve receptors and cancer therapies. Its lead product Ceplene, is used concomitantly with low-dose interleukin-2, is intended as remission maintenance therapy in the treatment of acute myeloid leukemia for adult patients. The company's other oncology compounds include AmiKet, a late-stage pain product candidate for the treatment of peripheral neuropathies, and two other oncology compounds in clinical development, that that were discovered using in-house technology and have been shown to act as vascular disruption agents in solid tumors. EpiCept was founded in March 1993 and is headquartered in Tarrytown, NY. | Direttore Tecnico/Scientifico/R&S | 29/05/2009 |
| University of California San Diego | Corporate Officer/Principal | - |
Cytovia, Inc.
 Cytovia, Inc. Miscellaneous Commercial ServicesCommercial Services Cytovia, Inc. provides biomedical research services. The firm discovers and develops therapeutics and products to assist physicians in curing cancer and certain degenerative diseases. The company was founded by Daniel Teper and is headquartered in San Diego, CA. | Corporate Officer/Principal | - |
| Maxim Pharmaceuticals, Inc. | Direttore Tecnico/Scientifico/R&S | - |
Formazione di Ben Tseng
| Brandeis University | Undergraduate Degree |
| Yale University | Doctorate Degree |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 3 |
|---|---|
EpiCept Corp.
EpiCept Corp. Pharmaceuticals: MajorHealth Technology EpiCept Corp. is a pharmaceutical company, which focuses on the clinical development and commercialization of pharmaceutical products for the treatment of cancer and pain. The company focuses on analgesics targeting peripheral nerve receptors and cancer therapies. Its lead product Ceplene, is used concomitantly with low-dose interleukin-2, is intended as remission maintenance therapy in the treatment of acute myeloid leukemia for adult patients. The company's other oncology compounds include AmiKet, a late-stage pain product candidate for the treatment of peripheral neuropathies, and two other oncology compounds in clinical development, that that were discovered using in-house technology and have been shown to act as vascular disruption agents in solid tumors. EpiCept was founded in March 1993 and is headquartered in Tarrytown, NY. | Health Technology |
| Maxim Pharmaceuticals, Inc. | Health Technology |
Cytovia, Inc.
Cytovia, Inc. Miscellaneous Commercial ServicesCommercial Services Cytovia, Inc. provides biomedical research services. The firm discovers and develops therapeutics and products to assist physicians in curing cancer and certain degenerative diseases. The company was founded by Daniel Teper and is headquartered in San Diego, CA. | Commercial Services |
- Borsa valori
- Insiders
- Ben Tseng
